MIRATI THERAPEUTICS INC - COM (MRTX)

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / COM
Total 13F shares
81,015,221
Share change
+15,201,254
Total reported value
$3,529,100,894
Put/Call ratio
32%
Price per share
$43.56
Number of holders
212
Value change
+$678,498,915
Number of buys
137
Number of sells
84

Institutional Holders of MIRATI THERAPEUTICS INC - COM (MRTX) as of Q3 2023

As of 30 Sep 2023, MIRATI THERAPEUTICS INC - COM (MRTX) was held by 212 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 81,015,221 shares. The largest 10 holders included RTW INVESTMENTS, LP, Avoro Capital Advisors LLC, EcoR1 Capital, LLC, VANGUARD GROUP INC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, Boxer Capital, LLC, Aviva Holdings Ltd., STATE STREET CORP, and MORGAN STANLEY. This page lists 212 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.